Showing results 34 to 44 of 44
Issue Date | Title | Author(s) |
---|---|---|
2024-03 | Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy | Lee Young-Joo; Song, Sukyung; Yang, Suah; Kim, Jinseong; MOON, YU JEONG; Shim, Nayeon; Yoon, Hong Yeol; Kim, Se hoon; Shim, Man Kyu; Kim, Kwangmeyung |
2022-10 | Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity | Shim, Man Kyu; Yang, Suah; Park, Jooho; Yoon, Jun Sik; Kim, Jinseong; Moon, Yujeong; Shim, Nayeon; Jo, Mihee; Choi, Yongwhan; Kim, Kwang meyung |
2021-01 | Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular tomography | Lim, Seungho; Yoon, Hong Yeol; Park, Soon-Jung; Song, Sukyung; Shim, Man Kyu; Yang, Suah; Kang, Sun-Woong; Lim, Dong-Kwon; Kim, Byung-Soo; Moon, Sung-Hwan; Kim, Kwangmeyung |
2019-10 | Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy | Lim, Seungho; Park, Jooho; Shim, Man Kyu; Um, Wooram; Yoon, Hong Yeol; Ryu, Ju Hee; Lim, Dong-Kwon; Kim, Kwangmeyung |
2021-05-21 | Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy | Yang, Suah; Sun, In-Cheol; Hwang, Hee Sook; Shim, Man Kyu; Yoon, Hong Yeol; Kim, Kwangmeyung |
2023-10 | RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges | Lee, Jong Won; Shim, Man Kyu; Kim, Hyosuk; Jang, Hochung; Lee, Yuhan; Kim, Sun Hwa |
2022-03 | Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses | Kim, Jeongrae; Choi, Yongwhan; Yang, Suah; Lee, Jaewan; Choi, Jiwoong; Moon, Yujeong; Kim, Jinseong; Shim, Nayeon; Cho, Hanhee; Shim, Man Kyu; Jeon, Sangmin; Lim, Dong-Kwon; Yoon, Hong Yeol; Kim, Kwangmeyung |
2021-12 | The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis | Kim, Jinseong; Shim, Man Kyu; Cho, Young-Jae; Jeon, Sangmin; Moon, Yujeong; Choi, Jiwoong; Kim, Jeongrae; Lee, Jaewan; Lee, Jeong-Won; Kim, Kwangmeyung |
2022-04 | Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery | Shim, Man Kyu; Yang, Suah; Sun, In-Cheol; Kim, Kwangmeyung |
2019-12 | Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy | Um, Wooram; Park, Jooho; Ko, Hokyung; Lim, Seungho; Yoon, Hong Yeol; Shim, Man Kyu; Lee, Sangmin; Ko, Young Ji; Kim, Min Ju; Park, Jae Hyung; Lim, Dong-Kwon; Byun, Youngro; Kwon, Ick Chan; Kim, Kwangmeyung |
2021-07-27 | Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy | Choi, Jiwoong; Shim, Man Kyu; Yang, Suah; Hwang, Hee Sook; Cho, Hanhee; Kim, Jeongrae; Yun, Wan Su; Moon, Yujeong; Kim, Jinseong; Yoon, Hong Yeol; Kim, Kwangmeyung |